Effect of highly active antiretroviral therapy on response to therapy and survival in patients with AIDS-related non-Hodgkins lymphoma treated with CHOP
José‐Tomás Navarro(Universitat Autònoma de Barcelona), Evarist Feliú(Universitat Autònoma de Barcelona), Joan Romeu(Hospital Universitari Germans Trias i Pujol), Fuensanta Millá, Aurea M. Flores(Sylvester Comprehensive Cancer Center), Manuel Vaquero Abellán(Instituto Maimónides de Investigación Biomédica de Córdoba), Josep‐María Ribera(Universitat Autònoma de Barcelona), M. Batlle, Albert Oriol(Institut Català d'Oncologia)
Unknown
August 2, 1999
Cited by 0
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719